Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Journal of Digital Imaging|July 5, 2022
Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective StudyJoy Tzung-Yu Wu, Miguel Ángel Armengol de la Hoz, Po-Chih Kuo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2020
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100Markus Moehler, Mikhail Dvorkin, Narikazu Boku, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2018
Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic TherapiesRodrigo A Toledo, Elena Garralda, Maria Mitsi, et al.European Journal of Cancer (Oxford, England : 1990)|February 14, 2025
Health-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 studyAlberto Sobrero, Arvind Dasari, Jeneth Aquino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2026
Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancersLaura Visa, Jordi Badia-Ramentol, Maria Concepción Fernández, et al.The New England Journal of Medicine|February 25, 2021
Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Norbert Bräu, Michael Waters, et al.American Journal of Clinical Oncology|November 29, 2024
Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait ProgramCésar Muñoz, María-C Riesco Martinez, Lisardo Ugidos, et al.The Oncologist|March 13, 2020
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)Johanna C Bendell, Tamara Sauri, Antonio Cubillo Gracián, et al.JAMA Oncology|February 10, 2018
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical TrialClara Montagut, Guillem Argilés, Fortunato Ciardiello, et al.Neuroendocrinology|July 11, 2018
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine TumoursEric Raymond, Matthew H Kulke, Shukui Qin, et al.Pageof 6